Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use

• Egile Nagusiak: Serafina Perrone (Egilea), Chiara Lembo (Egilea), Federica Gironi (Egilea), Chiara Petrolini (Egilea), Tiziana Catalucci (Egilea), Giulia Corbo (Egilea), Giuseppe Buonocore (Egilea), Eloisa Gitto (Egilea), Susanna Maria Roberta Esposito (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Protective strategies against perinatal brain injury represent a major challenge for modern neonatology. Erythropoietin (Epo) enhances endogenous mechanisms of repair and angiogenesis. In order to analyse the newest evidence on the role of Epo in prematurity, hypoxic ischemic encephalopathy (HIE) an...